Previous 10 | Next 10 |
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 40th Annual J.P. Morgan Healthcare Virtual Conference on Monday, January 10, 2022 at 2:15 p.m. ET. Investo...
Expands women’s health pipeline with novel candidates targeting endometriosis and polycystic ovarian syndrome (PCOS) Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage ...
Organon has seen material share price weakness as of late. The selling appears to be unjustified, however, considering Organon's recent business fundamentals. Meanwhile, OGN pays a respectable dividend with a low payout ratio, and has growth catalysts in its Women's Health and Bio...
Organon fell after posting quarterly results. Shareholders are nervous about recent acquisition. Fair value introduced. For further details see: Why Buy Organon After Shares Fell Below $30
Organon & Co. (OGN) 4th Annual Evercore ISI HealthCONx Conference December 1, 2021 1:50 PM ET Company Participants Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Umer Raffat - Evercore Eric Musonza - Evercore Presentation Umer Raffat 00:00 Hello, everyone. Thank you for ...
Merck continues to impress with strong growth in its key franchises. It maintains a very strong balance sheet, and just increased its dividend, which remains well-covered by earnings. Recent perceived headwinds have driven the share price back to bargain territory. For furth...
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021 at 1:50 p.m. ET. Investors, a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Spin-off stocks have been in the limelight in recent weeks. For instance, Johnson & Johnson (NYSE: JNJ ) recently announced it will spin off its consumer health division and instead focus on pharmaceuticals an...
Berkshire Hathaway's 13F stock portfolio value remained almost steady at ~$293B. Their largest three holdings are at two-thirds of the entire portfolio. Berkshire Hathaway increased Chevron while reducing Charter Communications, AbbVie, Marsh & McLennan, and Bristol-Myers Squi...
Glenview Capital takes new stakes in CCC Intelligent Solutions (NYSE:CCCS) with 2.41M shares, Willis Towers Watson (NASDAQ:WLTW) with 833K shares, and Organon (NYSE:OGN) with 753K shares. Exits Walgreens Boots Alliance (NASDAQ:WBA), Quantum-Si (NASDAQ:QSI), and Medtronic (NYSE:MDT). Boosts st...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...